Polycystic Ovary Syndrome

© Peanut, Biotic Artlab

Polycystic Ovary Syndrome

Polycystic ovary syndrome (PCOS) is a prevalent endocrine disorder affecting women of reproductive age. It is characterized by a triad of hyperandrogenism (elevated levels of circulating androgens (male sex hormones), ovulatory dysfunction (irregular or absent ovulation) and polycystic ovaries (ovaries with multiple small follicles on ultrasound).

PCOS is a leading cause of female infertility, impacting an estimated 6% to 12% (up to 5 million) of reproductive-aged women in the US, according to the CDC. The exact etiology remains unknown, and treatment approaches are primarily symptom-based and empirical. Importantly, PCOS can increase a woman’s risk of developing type 2 diabetes and cardiovascular disease, necessitating long-term management considerations.

Diagnostic workup:

Detailed history: Menstrual irregularities, infertility history, current medications, past medical conditions, and family history.

Physical examination: Assess for signs of hyperandrogenism (hirsutism, acne), central obesity, and potential insulin resistance (acanthosis nigricans).

Pelvic examination: May reveal clitoromegaly or ovarian enlargement.

Laboratory investigations:

Hormone panel: To evaluate for causes of menstrual dysfunction or androgen excess.

Fasting lipid profile (cholesterol, triglycerides).

Glucose tolerance test to assess insulin sensitivity.

Pelvic ultrasound: Evaluate ovarian morphology and endometrial thickness.

Symptom management: Addressing menstrual irregularities, hirsutism, acne, and infertility. Mitigating potential metabolic complications (reducing the risk of type 2 diabetes and cardiovascular disease).

Treatment:

Lifestyle modifications: Focusing on weight management and improving insulin sensitivity through diet and exercise.

Medications: Tailored based on individual needs and presenting symptoms. Options include:

Oral contraceptives: Regulate menstrual cycles and suppress androgen levels.

Progestins: Prevent endometrial hyperplasia in women who do not ovulate regularly.

Metformin: First-line therapy for insulin resistance and improving ovulation rates.

Clomiphene or Letrozole: Ovulation induction medications for infertility.

Gonadotropins: For women with severe anovulation.

Long-term management plans should address potential metabolic sequelae of PCOS, including diabetes and cardiovascular disease. Regular follow-up with a healthcare professional is crucial for ongoing monitoring and individualization of treatment strategies.

The images in this library are available to use for educational and training purposes only and are not intended to substitute professional medical advice, diagnosis, or treatment.

All images are covered under copyright and cannot be used for resale or any other commercial use.